Search

everythinglearnresearchcommunity

for

Search:↓

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

A mutation in the Sgkl gene causes defective hair growth in mice.

Delta1 is crucial for controlling skin cell growth and preventing tumors in mice.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

A new mouse mutation causes skin and hair issues, influenced by another gene.

A Chinese man with KID syndrome had a new mutation in the GJB2 gene.

Unmodified fullerene C60 promotes hair growth and may help treat hair loss.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

Seven new genetic risk areas for prostate cancer were found.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Boosting certain cell signals can prevent hair loss from cancer treatments.

A gene mutation in mice causes skin defects and early death.

CD133+ cells are crucial for hair growth.

Deleting MED1 in skin cells causes hair loss and skin changes.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

The K5 promoter controls gene expression in skin cells, with specific DNA segments crucial for targeting and regulation.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A specific microRNA, chi-miR-30b-5p, slows down the growth of hair-related cells by affecting the CaMKIIδ gene in cashmere goats.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

BMI1 is essential for preventing hair greying and maintaining hair color.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.